Association between proton pump inhibitor use and the risk of hepatobiliary cancers: A meta‐analysis

Documenti analoghi

• Proton pump inhibitors use and risk of liver cancer: Concerns to be addressed
  di: Wei‐Yu Kao, et al.
  Pubblicazione: (2024)
• Evaluating short‐term efficacy of proton pump inhibitors in GERD management
  di: Chih‐Ming Liang, et al.
  Pubblicazione: (2025)
• High‐dose ursodeoxycholic acid successfully treats overlap syndrome
  di: Tzu‐Rong Peng, et al.
  Pubblicazione: (2025)
• A pilot study comparing the initial clinical response to different proton pump inhibitors within first week in treating erosive esophagitis
  di: Min‐Kai Liao, et al.
  Pubblicazione: (2024)
• High recurrence of reflux symptoms following proton pump inhibitor therapy discontinuation in patients with Los Angeles grade A/B erosive esophagitis: What is the next step?
  di: Ming‐Wun Wong, et al.
  Pubblicazione: (2024)